Janakiraman Subramanian
75 posts

Janakiraman Subramanian
@RamSubraMD
Co - Director of Thoracic Oncology. Inova Schar Cancer Institute. Director Data Analysis Research Core ISCI
Virginia, USA Katılım Nisan 2020
213 Takip Edilen233 Takipçiler
Janakiraman Subramanian retweetledi

St Luke's precision oncology program reports improved outcomes for patients with @saintlukeskc molecular tumor board-directed therapy at the ESMO conference in Madrid

English

Congrats Ben and I am sure more to come
Ben Ponvilawan, MD, MS@BPonvilawan
Just published in JTO: authors.elsevier.com/c/1hcLO5Xq2QUw… STK11 and KEAP1 mutations confer less OS and PFS benefit in metastatic NSCLC, but ICI doublets might overcome the resistance. Thank you @RamSubraMD @dhruvsxu for guiding this project through!
English
Janakiraman Subramanian retweetledi

Continuing at MSL Arlington VA with Lung Cancer 🫁session with very comprehensive overview from great colleagues @VamsiVelcheti TKI @RamSubraMD IO and @NaglaAKarimMD resistance. An amazing session chairing by my friend Amin Benyounnes @InovaSchar @mecmededucation @OncoAlert




English
Janakiraman Subramanian retweetledi

Very interesting update on Prostate Cancer Precision Oncology from my former colleague Dr. Arif Hussain from @UMBaltimore @UMGCCC at MSL Arlington @RamSubraMD @NaglaAKarimMD @InovaSchar @OncoAlert @isliquidbiopsy @mecmededucation


English

Dr Ashiq Masood discussing molecular classification in colorectal cancer and the role of targeted therapy #MLSArlington @mecmededucation @ashiq_masood


English

Dr Christian Rolfo giving a lecture on the recent advances in precision oncology and the role of liquid biopsy #MLSArlington @mecmededucation @ChristianRolfo

English

Dr Yacur giving a master lecture on the recent advances in breast cancer #MLS Arlington @mecmededucation @InovaSchar

English

Getting started with MLS Arlington. Promises to be a great day of learning. @mecmededucation @CancerExpertNow

English

Inova Lung Cancer Researcher Leads Study Offering New Hope for Small Cell Lung Cancer Patients - Inova Newsroom @InovaSchar @InovaHealth @LaurenByersMD @ReckampK @RamSubraMD @triparnasen inovanewsroom.org/expert-comment…
English

Magical times on the Nile
Triparna Sen (Sen-Lab)@triparnasen
2 weeks ago- a magical cruise on the Nile with my brilliant colleagues. A memorable evening of #friendship, #collaboration & #strategies to control #lungcancer. @NaglaAKarimMD @karenkellymd @maiofegypt @BrainTumorDoc @RamSubraMD #SCLC #WomenInSTEM #womeninthoraciconcology
English
Janakiraman Subramanian retweetledi

Two days of phenomenal #science, #strategy, #DEI, #collaboration, & #friendship at the Annual Meeting of #ESRN #ECRN at Cairo. Enjoying the history and culture of Egypt with these amazing group of #physicians & #scientists.
#lungcancer #diversity #MENASA #LCSM #SCLC #Inclusion




Cairo, Egypt 🇪🇬 English
Janakiraman Subramanian retweetledi

My job makes me meet wonderful people.
In Cairo with @drgandara @NaglaAKarimMD @karenkellymd @RamSubraMD @BrainTumorDoc Phil Mack. Gearing up for discussing strategies about #lungcancer #SCLC #treatment #airpollution #precisionmedicine. #MENASA #Diversity #LCSM @IcahnMountSinai


Cairo, Egypt 🇪🇬 English

Vivek @VivekSubbiah is a globally recognized leader for precision medicine and early-phase research.
This is a big big coup for @SarahCannonDocs !
Congrats Vivek !
@BusinessWire
businesswire.com/news/home/2023…
English

@donnashort Hey Donna enjoyed working with you. Wish you the very best.
English

New beginnings! Thank you @MJHLifeSciences for seven years of #innovation on your playground of products. Getting to build and lead an incredibly highly talented productive team. Starting & leading the women in leadership group. Take care of my docs and pharma friends!

English
Janakiraman Subramanian retweetledi

Our lung cancer session at 2023 #PRIMO Hawaii @medical_cons meeting with @EdgardoSantosMD jorge nieva @RamSubraMD #LCSM @OLACANCER1 @FLASCO_ORG #Immunotherapy #Immunology #lungcancer

English

Dr @edgardo_ny discussing targeted therapy updates for patients with KRAS G12C, RET, BRAF, TRK alterations at #PRIMO2023

English
Janakiraman Subramanian retweetledi

Great talk by @RamSubraMD making the case that The Future of Lung Cancer Screening in High Risk Non-Smokers is already here!
➡️ family history, biomarkers can select non- smokers at risk
#lcsm
@FLASCO_ORG Early Lung Cancer Summit
@LuisERaez1




English
